Akribion Therapeutics
GermanyEntry
2025
Hold
1yr
Status
Active
Who owns Akribion Therapeutics?
Akribion Therapeutics is currently owned by High-Tech Gruenderfonds (HTGF) through HTGF IV (2022 vintage), since 2025. Across its history, Akribion Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-08-11
Most recent investor
High-Tech Gruenderfonds (HTGF)HTGF IV · 2022 · VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
More from HTGF IV
Other portfolio companies in the same fund.
Switzerland
Denmark
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Akribion Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Akribion Therapeutics?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Akribion Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue